All studies
RecruitingTherapeutic exploratory (Phase II)Interventional

Validation of ICG-99mTc-nanoscan as hybrid tracer for sentinel node biopsy - NANOSCAN

When doctors treat cancers such as melanoma, mouth cancer, or penile cancer, they often need to check the 'sentinel' lymph nodes. These are the very first lymph nodes cancer cells would spread to. Usually, doctors inject a tiny amount of a safe radioactive liquid to show these nodes on scans before surgery. This clinical trial is testing a new combined tracer called ICG-99mTc-nanoscan. It brings together the standard radioactive marker with a safe green dye that glows under a special light. The goal is to see whether this hybrid tracer shows lymph nodes just as clearly as the usual method on scans taken before surgery, and whether the glowing colour helps surgeons spot the nodes more easily in the operating room. Taking part involves receiving the injection and having standard imaging before your planned operation.

At a glance

Status
Recruiting
Phase
Therapeutic exploratory (Phase II)
Sponsor
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Enrolment target
29
Start
16 Dec 2024

What is this study about?

Lymph nodes are small, bean-shaped glands that act as filters throughout your body. In cancers of the skin (melanoma), mouth, or penis, doctors often need to remove and examine the first lymph node that drains fluid from the tumour. This is known as the 'sentinel node'. If this node is clear of cancer, it often means the other lymph nodes are healthy too, sparing you from more extensive surgery.

Normally, doctors locate this sentinel node by injecting a tiny amount of a safe radioactive tracer around the tumour. Special scans, called lymphoscintigraphy and SPECT/CT, detect the faint radioactive signal and create a map to guide the surgeon. While this works well, surgeons must rely on handheld sound probes during the operation rather than actually seeing the node change colour.

This trial investigates an upgraded tracer named ICG-99mTc-nanoscan. It combines the proven radioactive tracer with a medical dye called indocyanine green (ICG). This dye glows bright green under near-infrared light. Researchers want to confirm that this combined tracer is just as reliable as the standard tracer at mapping the nodes before surgery, while giving surgeons the added advantage of seeing the nodes glow directly during the operation.

By comparing how well the nodes appear on scans and during surgery, this research aims to make sentinel node biopsies quicker, more precise, and easier for surgical teams in the NHS and worldwide.

Key takeaways

  • Tests a new 2-in-1 tracer that combines a radioactive marker with a glowing green dye.
  • Aims to make finding key sentinel lymph nodes easier and more accurate for surgeons.
  • Open to adults with melanoma of the head, neck, or upper trunk, mouth cancer, or penile cancer.
  • Fits alongside your planned cancer surgery with standard imaging scans.
  • Participation is voluntary and does not replace your standard NHS surgical care.

Who may be eligible?

This study is open to adults aged 18 and over who have been diagnosed with specific types of cancer. These include melanoma of the head, neck, or upper chest/back, cancers of the mouth, or cancer of the penis.

To be eligible, your medical team must already have planned for you to have a sentinel lymph node biopsy as part of your normal cancer treatment. Both men and women can join.

You may not be able to take part if you have known severe allergies to the dyes used, or if you are pregnant or breastfeeding, as small amounts of radiation are involved. Your hospital care team will check your full medical history to confirm if this trial is right for you.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am aged 18 or older.
  2. I have been diagnosed with melanoma (head, neck, or upper trunk), mouth cancer, or penile cancer.
  3. My doctor has already recommended a sentinel lymph node biopsy as part of my surgery.
  4. I do not have a known allergy to iodine or indocyanine green dye.
  5. I am not pregnant or breastfeeding.
Answer every question to see your result.

What does participation involve?

If you take part, your care will closely match standard NHS treatment, with a few extra imaging checks. Before your planned surgery, a doctor will inject the new hybrid tracer into the skin around your tumour site. You will then have routine scans (lymphoscintigraphy and SPECT/CT) to see which lymph nodes absorb the tracer.

During your scheduled surgery, your surgeon will look for the sentinel nodes using both a radiation probe (standard practice) and a special camera that detects the glowing green dye. The surgeon will remove the identified nodes and send them to the laboratory as normal.

Your participation mainly takes place on the day of your scans and surgery. After your operation, you will attend your usual post-surgery hospital checkups. The study does not require months of extra hospital visits beyond your normal recovery follow-up.

Potential risks and benefits

Taking part may not give you any direct health benefit over the standard procedure, but it could help surgeons locate your lymph nodes more easily on the day. Your participation will also help improve surgical techniques for future cancer patients. The risks are low; the injection may sting briefly, and the tracer carries a very low dose of radiation, similar to routine diagnostic X-rays. Mild allergic reactions to the dye are rare. Joining the trial is entirely voluntary, and you can withdraw at any point without it affecting your NHS treatment or your relationship with your doctors.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    Netherlands

Common questions

What is a sentinel lymph node?

It is the first lymph node to which cancer cells are most likely to spread from a primary tumour. Checking it tells doctors whether the cancer has started to spread.

Is the radioactive tracer dangerous?

No. The tracer uses a very small, safe dose of radiation that is routinely used in NHS hospitals every day. It leaves your body naturally within a short time.

What does the green dye do?

The green dye (ICG) shines under a special infrared camera. This allows the surgeon to see the exact node glowing on a screen in real time during the operation.

Will taking part delay my cancer surgery?

No. The scans and tracer injections are planned to fit directly into your existing surgical schedule so your treatment is not delayed.

Can I leave the study if I change my mind?

Yes, absolutely. You can withdraw at any time without giving a reason, and you will receive the standard NHS care as planned.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Validation of ICG-99mTc-nanoscan as hybrid tracer for sentin…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.